Condition (MeSH)
Seroma
ClinicalTrials.gov lists 92 trials for Seroma or a narrower condition beneath it. Baxter Healthcare Corporation has the most among industry and government lead sponsors, with 3.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
92 of the 92 trials are tagged with Seroma itself; the rest are tagged with a narrower condition beneath it.
When did Seroma trials start? (25)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 8
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 7 |
| 2025 | 3 |
| 2024 | 4 |
| 2023 | 6 |
| 2022 | 3 |
| 2021 | 7 |
| 2020 | 6 |
| 2019 | 2 |
| 2018 | 8 |
| 2017 | 4 |
Showing 10 of 25 earlier years.
No forecast is made for this condition: it averages 4.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 36 months from start to primary completion across 9 trials still running at the 2026-10-09 snapshot; registered median of 27 months across 44 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Seroma trials in? (7)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 4 |
| Phase 2/3 | 2 |
| Phase 3 | 3 |
| Phase 4 | 8 |
| Not applicable | 69 |
| Observational | 5 |
How many Seroma trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 10 |
| Active, not recruiting | 1 |
| Completed | 43 |
| Terminated | 3 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Seroma trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Baxter Healthcare Corporation | 3 |
| Instituto Nacional de Cancer, Brazil | 2 |
| Nanchong Central Hospital | 2 |
Which drugs are being tested for Seroma? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| METHYLPREDNISOLONE | 2 |
Interventions as named in the registry (14)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Fibrin Sealant | 2 |
| Arista | 2 |
| acid tranexamic | 2 |
| Doxycline | 2 |
| Artiss | 1 |
Showing 5 of 14 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Seroma trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Death | 40 | 1 |
| Wound Seroma | 16 | 1 |
| Surgical seroma | 12 | 1 |
| Wound cellulitis | 5 | 1 |
| Infected seroma | 4 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Seroma? (177)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Quilt technique after mastectomy: stepped-wedge randomized cluster trial showing superior textbook outcome and reduced healthcare utilization. | The British journal of surgery | 2025 | Yes |
| Seroma control in axillary lymphadenectomy with Glubran 2® without drain. Multicenter, prospective, randomized, clinical trial. GALA-ND study (Glubran, Axillary Lymphadenectomy, Ambulatory, No Drain). | Trials | 2024 | Yes |
| Intraoperative Hypertonic Saline Irrigation Preventing Seroma Formation in the Treatment of Axillary Bromhidrosis. | Aesthetic plastic surgery | 2024 | Yes |
| Seroma incidence and risk factors in women undergoing mastectomies as surgical breast cancer treatment. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2024 | Yes |
| Clinical Experience with Compression Taping to Treat Seroma After Breast Cancer Surgery: A Medical Device Clinical Study. | Advances in skin & wound care | 2022 | Yes |
Showing 5 of 177 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.